- UK says vaccine protects against meningitis strain in outbreak
- Two deaths reported, 18 confirmed cases, others under investigation
- Over 2,300 vaccinated, nearly 9,800 antibiotic courses administered
- Authorities expand vaccination amid ongoing outbreak in southeast England
The preliminary laboratory tests conducted by British health officials indicated early that the strain of meningitis responsible for a meningitis outbreak that has claimed the lives of two individuals in southeast England should be covered by the vaccine being given to students.
The virus is reported to be of the ST-41/44 category of meningococci, which has been present in the country over the last several years. UKHSA confirmed that this has been the strain. Reuters reported that the vaccine Bexsero deployed as a response to the outbreak is supposed to be effective against this variant, which is a good news since the cases are still coming through.
The epidemic has also led to an immediate public health response, such as mass vaccination efforts and massive consumption of antibiotics. Officials reported 2360 individuals have gotten the vaccination to date, and about 9840 courses of antibiotics have been dispensed to prevent the transmission.
According to the data mentioned by Reuters, as of Thursday evening, 18 confirmed cases were identified, and 11 other cases were under investigation.
Inoculation Campaigns Step-Up in at-Risk Regions
Health officers have opened up more vaccine centers especially among students in areas of outbreak like Kent which have been the epicenter of the outbreak. Queues in the centers providing the vaccination have become huge, because many want to be vaccinated.
UKHSA called the establishment of the effectiveness of vaccines "a significant source of reassurance", but continued by stating that further work is in progress. The government has been highlighting the fact that swift vaccination is one of the tools that help to curb the spread.
The government has taken the step to increase access to vaccines and treatment as its containment policy. Health Secretary Wes Streeting indicated that "attention had been paid to fast intervention to avoid further spread".
The outbreak also precipitated an increase in national demand of the MenB vaccine that has created supply constraints in certain regions. In the same way, Pharmacy chain Boots has reported shortages in Britain in several parts of the country.
Threat Of Further Dissemination Continues To be Under Consideration
Although the outbreak is at the moment localized to southeast England, authorities have not dismissed the likelihood of other cases being reported in the other parts of the country. According to Kent County Council, the director of public health, Anjan Ghosh, stated that "there could be a few cases of households outside of Kent."
Governments are keeping a close watch on the situation, including assessing the need to implement wider vaccination measures. But officials warned that it is too soon to know whether a nationwide vaccination programme will be endorsed.
Government estimates indicate that invasive meningitis is usually registered at approximately one case a day in Britain so the current outbreak is a matter of great concern to the wider population.
Contact tracing, the distribution of antibiotics, and targeted vaccination of the public are being prioritized by the health teams working in public health to control the outbreak gathering as much data on the pattern of transmission and the risk factors.
Healthcare System Reacts to Contain Outbreak
The response points out the dependence of the UK on structured public health responses to control the outbreak of infectious diseases especially in the high-density environment like the university.
Specialists observe that meningitis may transmit quickly in places of close contacts, and it is important to intervene as early as possible. The application of both preventive antibiotics and vaccination is a dual strategy of limiting both the immediate and secondary transmission.
Authorities have emphasized that the situation is still critical but having a successful vaccine is one of the most important advantages when it comes to controlling the outbreak.
This development will change depending on whether or not the current levels of surveillance have been effective and whether or not the current levels of containment have been effective as officials aim to mitigate the additional deaths and expansion.
